Find Salicin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 138-52-3, Salicoside, Salicine, D-(-)-salicin, Salicyl alcohol glucoside, D(-)-salicin
Molecular Formula
C13H18O7
Molecular Weight
286.28  g/mol
InChI Key
NGFMICBWJRZIBI-UJPOAAIJSA-N
FDA UNII
4649620TBZ

Salicin
salicin is a natural product found in Salix atrocinerea, Salix candida, and other organisms with data available.
1 2D Structure

Salicin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol
2.1.2 InChI
InChI=1S/C13H18O7/c14-5-7-3-1-2-4-8(7)19-13-12(18)11(17)10(16)9(6-15)20-13/h1-4,9-18H,5-6H2/t9-,10-,11+,12-,13-/m1/s1
2.1.3 InChI Key
NGFMICBWJRZIBI-UJPOAAIJSA-N
2.1.4 Canonical SMILES
C1=CC=C(C(=C1)CO)OC2C(C(C(C(O2)CO)O)O)O
2.1.5 Isomeric SMILES
C1=CC=C(C(=C1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O
2.2 Other Identifiers
2.2.1 UNII
4649620TBZ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Salicyl Alcohol Glucoside

2.3.2 Depositor-Supplied Synonyms

1. 138-52-3

2. Salicoside

3. Salicine

4. D-(-)-salicin

5. Salicyl Alcohol Glucoside

6. D(-)-salicin

7. (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)tetrahydro-2h-pyran-3,4,5-triol

8. 2-(hydroxymethyl)phenyl Beta-d-glucopyranoside

9. Saligenin Beta-d-glucopyranoside

10. Saligenin-beta-d-glucopyranoside

11. D-salicin

12. Alpha-hydroxy-o-tolyl Beta-d-glucopyranoside

13. Salicinum

14. 2-(hydroxymethyl)phenyl-beta-d-glucopyranoside

15. Nsc 5751

16. O-(hydroxymethyl)phenyl Beta-d-glucopyranoside

17. Beta-d-glucopyranoside, 2-(hydroxymethyl)phenyl

18. Benzyl Alcohol, O-hydroxy-, O-glucoside

19. Ai3-19099

20. Spectrum1502255

21. B-d-glucopyranoside, 2-(hydroxymethyl)phenyl

22. Chebi:17814

23. Nsc-5751

24. D-()-salicin

25. (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol

26. 4649620tbz

27. Sdccgmls-0066698.p001

28. Ncgc00142605-01

29. Mfcd00006590

30. (2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(2-(hydroxymethyl)-phenoxy)tetrahydro-2h-pyran-3,4,5-triol

31. Smr000112301

32. Salicin [usp]

33. Sr-05000001594

34. Salicin (6ci,8ci)

35. Einecs 205-331-6

36. Delta-salicin

37. Unii-4649620tbz

38. 2-(hydroxymethyl)phenyl Hexopyranoside

39. Saligenin Glucoside

40. Sa0

41. D-(?)-salicin

42. Spectrum_001230

43. 2-(hydroxymethyl)phenyl-.beta.-d-glucopyranoside

44. Salicin [inci]

45. Salicin [mi]

46. Salicinum [hpus]

47. Spectrum2_000756

48. Spectrum3_000948

49. Spectrum4_001058

50. Spectrum5_000971

51. Bmse000315

52. Salicyl Alcohol-b-glucoside

53. Saligenin Bet.-d-glucoside

54. D-salicin [usp-rs]

55. Schembl24936

56. Kbiogr_001356

57. Kbioss_001710

58. Saligenin-b-d-glucopyranoside

59. Mls000563050

60. Mls001306490

61. Divk1c_000030

62. S0625_sigma

63. Spbio_000772

64. Chembl462997

65. Megxp0_000685

66. Salicin (salicoside, Salicine)

67. Acon1_000373

68. Hms500b12

69. Kbio1_000030

70. Kbio2_001710

71. Kbio2_004278

72. Kbio2_006846

73. Kbio3_002016

74. Dtxsid10883326

75. Ninds_000030

76. Hms1921p08

77. Hms2092f14

78. Hms2268j11

79. Hms3884b15

80. Pharmakon1600-01502255

81. Hy-n0149

82. Saligenin Beta-delta-glucopyranoside

83. Saligenin-beta-delta-glucopyranoside

84. Zinc3847505

85. D-(-)-salicin, Analytical Standard

86. Ccg-40332

87. Nsc758201

88. S2351

89. Zinc03847505

90. Akos004907439

91. Ac-8042

92. Cs-8027

93. D-(-)-salicin, >=99% (gc)

94. Nsc-758201

95. Idi1_000030

96. Ncgc00142605-02

97. Ncgc00142605-04

98. (2s,4s,5s,3r,6r)-6-(hydroxymethyl)-2-[2-(hydroxymethyl)phenoxy]-2h-3,4,5,6-tet Rahydropyran-3,4,5-triol

99. Salicyl Alcohol Glucoside [who-dd]

100. Sbi-0051746.p002

101. 2(hydroxymethyl)phenyl-beta-d-glucopyranoside

102. N1880

103. S0003

104. Sw219123-1

105. C01451

106. 2-(hydroxymethyl)-phenyl-beta-d-glucopyranoside

107. 2-(hydroxymethyl)phenyl-&beta-d-glucopyranoside

108. 2-(hydroxymethyl)phenyl-o-beta-d-glucopyranoside

109. Ab00052296_07

110. 138s523

111. Q419173

112. Sr-05000001594-1

113. Sr-05000001594-2

114. Brd-k64614248-001-02-4

115. Brd-k64614248-001-06-5

116. Ead32be1-198e-432c-9f44-dc0dc9a3305b

117. Salicin, European Pharmacopoeia (ep) Reference Standard

118. D-salicin, United States Pharmacopeia (usp) Reference Standard

119. Wurcs=2.0/1,1,0/[a2122h-1b_1-5_1*o(c^zc^zc^zc^zc^zc^e$3)/4co]/1/

120. 2-(hydroxymethyl)phenyl-beta-d-glucopyranoside, Salicoside, Salicyl Alcohol Glucoside, Saligenin Beta-d-glucoside

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 286.28 g/mol
Molecular Formula C13H18O7
XLogP3-1.2
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass286.10525291 g/mol
Monoisotopic Mass286.10525291 g/mol
Topological Polar Surface Area120 Ų
Heavy Atom Count20
Formal Charge0
Complexity300
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Cyclooxygenase Inhibitors

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)


REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty